Showing results (621-630 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|January 14, 2014
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannomaMarco Giovannini, Nicolas-Xavier Bonne, Jeremie Vitte, et al.
Neuro-Oncology|June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsDiego M Marzese, Richard A Scolyer, Maria Roqué, et al.
Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.
Neuro-Oncology|July 5, 2014
A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromesAdriaan H de Jongste, Teun van Gelder, Jacoline E Bromberg, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Neuro-Oncology|September 12, 2012
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotypeYuji Piao, Ji Liang, Lindsay Holmes, et al.
Neuro-Oncology|August 8, 2012
A population-based study on the effect of temozolomide in the treatment of glioblastoma multiformePål A Rønning, Eirik Helseth, Torstein R Meling, et al.
Neuro-Oncology|September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology|June 20, 2012
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR ImagingRamon F Barajas, Joanna J Phillips, Rupa Parvataneni, et al.
Neuro-Oncology|June 20, 2012
Clinical and molecular characteristics of congenital glioblastomaMargaret E Macy, Diane K Birks, Valerie N Barton, et al.
Pageof 315